Recommended

Pharmalot
Pharmalot March 25, 2025

STAT Plus: Pharmalittle: We’re reading about NIH removing scientific advisers, GSK’s shingles shot, and more

By Ed Silverman

Pharmalot
Pharmalot March 24, 2025

STAT Plus: Pharmalittle: We’re reading about 23andMe bankruptcy filing, the case against ‘global freeloading,’ and more

By Ed Silverman

advertisement

Pharmalot
Pharmalot March 21, 2025

STAT Plus: Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot
Pharmalot March 21, 2025

STAT Plus: Pharmalittle: We’re reading about J&J building U.S. plants, a weight loss-drug race in India, and more

By Ed Silverman

Pharmalot
Pharmalot March 20, 2025

STAT Plus: Tapping the potential of GLP-1 drugs requires integrated care and overcoming inequities, executives say

By Ed Silverman

Subscriber Picks